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Abstract
Objective:  To  evaluate  the  validity  of  clinical  and  laboratory  signs  to  serious  dengue  disease  in
hospitalized  children.
Methods:  Retrospective  cohort  of  children  (<18  years)  hospitalized  with  dengue  diagnosis
(2007--2008).  Serious  dengue  disease  was  deﬁned  as  death  or  use  of  advanced  life  support
therapy. Accuracy  measures  and  area  under  the  receiver  operating  characteristic  curve  were
calculated.
Results: Of  the  total  (n  =  145),  53.1%  were  female,  69%  aged  2--11  years,  and  15.9%  evolved
to the  worse  outcome.  Lethargy  had  the  best  accuracy  (positive  likelihood  ratio  >19  and  neg-
ative likelihood  ratio  <0.6).  Pleural  effusion  and  abdominal  distension  had  higher  sensitivity
(82.6%). History  of  bleeding  (epistaxis,  gingival  or  gastrointestinal  bleeding)  and  severe  hem-
orrhage  (pulmonary  or  gastrointestinal  bleeding)  in  physical  examination  were  more  frequent
in serious  dengue  disease  (p  <  0.01),  but  with  poor  accuracy  (positive  likelihood  ratio  =  1.89  and
3.89; negative  likelihood  ratio  =  0.53  and  0.60,  respectively).  Serum  albumin  was  lower  in  seri-
ous dengue  forms  (p  <  0.01).  Despite  statistical  signiﬁcance  (p  <  0.05),  both  groups  presented
thrombocytopenia.  Platelets  count,  hematocrit,  and  hemoglobin  parameters  had  area  under
the curve  <0.5.
Conclusions:  Lethargy,  abdominal  distension,  pleural  effusion,  and  hypoalbuminemia  were  the
best clinical  and  laboratorial  markers  of  serious  dengue  disease  in  hospitalized  children,  while
bleeding,  severe  hemorrhage,  hemoconcentration  and  thrombocytopenia  did  not  reach  ade-
quate diagnostic  accuracy.  In  pediatric  referral  hospitals,  the  absence  of  hemoconcentration
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does  not  imply  absence  of  plasma  leakage,  particularly  in  children  with  previous  ﬂuid  replace-
ment. These  ﬁndings  may  contribute  to  the  clinical  management  of  dengue  in  children  at
referral hospitals.
©  2016  Published  by  Elsevier  Editora  Ltda.  on  behalf  of  Sociedade  Brasileira  de  Pediatria.  This  is
an open  access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/
by-nc-nd/4.0/).
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hospitalizadas
Resumo
Objetivo:  Avaliar  a  validade  dos  sinais  clínicos  e  laboratoriais  para  o  dengue  com  evoluc¸ão  grave
em crianc¸as  hospitalizadas.
Métodos:  Coorte  retrospectivo  de  crianc¸as  (<18  anos)  internadas  com  dengue  (2007--2008).
Evoluc¸ão grave  foi  deﬁnida  como  óbito  ou  pelo  uso  de  terapia  de  suporte  avanc¸ado  de  vida.
Foram calculadas  medidas  de  acurácia  e  área  sob  a  curva  ROC.
Resultados:  Do  total  (n  =  145),  53,1%  casos  eram  do  sexo  feminino,  69%  de  2  a  11  anos  e  15,9%
evoluíram para  gravidade.  Letargia  obteve  a  melhor  acurácia  (razão  de  verossimilhanc¸a  pos-
itiva RVP  >  19  e  RV  negativa  RVN  <  0,6).  Derrame  pleural  e  distensão  abdominal  apresentaram
maior sensibilidade  (se  =  82,6%).  Relato  de  sangramentos  (epistaxe,  gengivorragia  ou  gastroin-
testinal) e  hemorragia  grave  (pulmonar  ou  gastrointestinal)  presente  no  exame  físico  foram
mais frequentes  nos  casos  com  evoluc¸ão  grave  (p  <0,01),  porém  com  baixa  acurácia  (RVP  =  1,89
e 3,89;  RVN  =  0,53  e  0,60,  respectivamente).  Os  níveis  de  albumina  sérica  foram  mais  baixos  nas
formas graves  (p  <0,01).  Ambos  os  grupos  apresentaram  trombocitopenia,  apesar  da  diferenc¸a
estatística  (p  <0,05).  Contagem  de  plaquetas,  hematócrito  e  hemoglobina  apresentaram  área
sob a  curva  ROC  <  0,5.
Conclusões:  Letargia,  distensão  abdominal,  derrame  pleural  e  hipoalbuminemia  foram  os
melhores marcadores  clínicos  e  laboratoriais  de  dengue  com  evoluc¸ão  grave  em  crianc¸as  hos-
pitalizadas,  enquanto  sangramento,  hemorragia  grave,  hemoconcentrac¸ão  e  trombocitopenia
não tiveram  boa  acurácia  diagnóstica.  Em  hospitais  de  referência  pediátricos,  a  ausência
de hemoconcentrac¸ão  não  implica  ausência  de  extravasamento  plasmático,  particularmente
quando há  reposic¸ão  anterior  de  volume.  Esses  resultados  podem  contribuir  para  o  manejo
clínico do  dengue  em  crianc¸as  em  hospitais  de  referência.
© 2016  Publicado  por  Elsevier  Editora  Ltda.  em  nome  de  Sociedade  Brasileira  de  Pediatria.  Este
e´ um  artigo  Open  Access  sob  uma  licenc¸a  CC  BY-NC-ND  (http://creativecommons.org/licenses/
by-nc-nd/4.0/).
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Dengue  is  an  acute  febrile  disease  caused  by  a  ﬂavivirus,
with  four  known  serotypes  (DENV-1,  DENV-2,  DENV-3,  and
DENV-4).  In  2013,  the  worldwide  estimate  of  dengue  infec-
tion  was  390  million  people,  96  million  of  whom  were
symptomatic.1 In  Brazil,  from  2000  to  2010,  there  was  an
increase  in  dengue  incidence,  accompanied  by  a  propor-
tional  increase  in  severe  cases.2 Dengue  has  mainly  affected
the  adult  population  in  Brazil,  but  the  epidemic  in  2008
showed  an  increased  incidence  in  individuals  under  15  years
of  age,  with  a  higher  proportion  of  severe  cases  in  this  age
group.2
The  four  serotypes  can  lead  to  variable  clinical  presenta-
tions,  ranging  from  asymptomatic  to  severe  forms.  Infants
and  preschoolers  frequently  present  an  undifferentiated
febrile  disease.  Coryza,  seizures,  nausea,  vomiting,  exan-
thema,  and  petechiae  are  more  frequent  in  children  under  2
years  of  age.3 Children  with  dengue  could  evolve  into  severe
forms  faster  than  adults,  especially  those  under  5  years.4
Signs  of  hypoperfusion  like  cold  skin,  oliguria,  and  slow
o
t
e
aapillary  reﬁll  can  appear  suddenly  after  a  few  days  of  the
ebrile  phase.5
In  1997,  the  World  Health  Organization  (WHO)  estab-
ished  a  classiﬁcation  of  dengue  cases:  dengue  fever  (DF)
nd  dengue  hemorrhagic  fever  (DHF).  DHF  is  subdivided
nto  four  stages  of  severity;  stages  III  and  IV  are  deﬁned
s  dengue  shock  syndrome  (DSS).  In  2009,  the  WHO  pro-
osed  a  new  classiﬁcation,  dengue  and  serious  dengue,  in
hich  dengue  is  subdivided  according  to  the  presence  or
bsence  of  the  following  warning  signs:  abdominal  pain,
ersistent  vomiting,  edema,  mucosal  bleeding,  lethargy,
rritability,  hepatomegaly  (>2  cm),  and  increased  hematocrit
oncurrent  with  decreased  platelet  count.6 This  new  classi-
cation  aimed  at  simpliﬁcation  and  changed  the  focus  from
emorrhage  to  plasma  leakage,  the  principal  factor  in  patho-
enesis  of  the  severe  forms.7
The  WHO  and  Brazilian  Ministry  of  Health  adopted  the  use
6,8f  warning  signs  for  clinical  case  management, although
heir  evidence  as  predictors  of  severity  is  not  consistent,
specially  in  children.9 Signs  and  symptoms  most  frequently
ssociated  with  severity  in  children  were:  spontaneous
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leeding,  hepatomegaly,  and  signs  of  plasma  leakage,  such
s  ascites  and  pleural  effusion,10,11 abdominal  pain,11,12
emoconcentration  and  thrombocytopenia,13--16 and  ele-
ated  plasma  levels  of  the  liver  enzyme  serum  glutamic
xaloacetic  transaminase  (SGOT).11,15 The  majority  of  stud-
es  deﬁned  platelet  count  below  50,000  per  mm3 as  a sign
f  poor  prognosis.13,14,16 Potts  et  al.15 found  that  leukocyte
ount  and  thrombocytopenia  are  less  signiﬁcant  for  predict-
ng  severity,  with  the  latter  more  important  for  the  diagnosis
f  dengue.
The  use  of  warning  signs  in  dengue  was  proposed  for  early
etection  of  potentially  severe  cases  for  timely  treatment,
o  avoid  unnecessary  hospitalizations,  and  to  decrease  the
ase-fatality  of  this  disease.6,8 However,  various  clinical  and
pidemiological  aspects  have  still  not  been  completely  elu-
idated,  especially  in  children.  In  Brazil,  the  2008  epidemic
howed  more  serious  dengue  cases  in  children  with  the  pri-
ary  infection,2 contrary  to  studies  in  Asia  that  showed
n  association  between  secondary  infection  and  severity.17
lthough  a  meta-analysis  of  37  international  studies  showed
n  inversely  proportional  association  between  age  and  DSS,
he  studies  were  highly  heterogeneous,  probably  due  to  wide
ariability  in  age  brackets  in  the  study  populations.17 In
his  study,  although  hemorrhage  appeared  as  a  predictor  of
everity,  this  sign  was  not  frequent  in  children.13 Finally,
he  majority  of  the  validation  studies17 on  warning  signs  for
engue  used  the  WHO  criterion  for  DHF  as  the  reference
tandard,9 which  incorporates  many  of  the  signs  and  symp-
oms  tested  as  predictors,  thus  committing  an  incorporation
ias  toward  diagnostic  studies,  with  a  tendency  to  overesti-
ate  accuracy  measurements.18
This  study  aimed  to  evaluate  the  validity  of  clinical  and
aboratorial  markers  for  serious  dengue  disease  in  a  cohort
f  children  hospitalized  during  the  2007--2008  epidemic  in
he  city  of  Rio  de  Janeiro,  Brazil.  During  this  epidemic,  there
ere  more  than  100,000  suspected  dengue  cases  reported
o  the  local  health  information  system;  38,808  were  con-
rmed  and  classiﬁed  according  to  the  WHO  system  of  1997.
f  those,  42.3%  were  under  18  years  of  age.  At  that  time,
he  serotypes  circulating  were  DENV-2  and  DENV-3.
ethods
his  was  a  retrospective  cohort  study  in  a  pediatric  refer-
al  hospital  in  the  city  of  Rio  de  Janeiro,  Brazil.  The  study
ncluded  all  children  and  adolescents  (from  2 months  to  18
ears)  hospitalized  with  dengue  during  the  epidemic  from
ovember  2007  to  May  2008.
Since  it  was  sought  to  study  clinical  and  laboratorial
arkers  of  serious  dengue  disease  and  shock  was  related  to
he  outcome  variable,  cases  who  presented  a  clinical  picture
onsistent  with  shock  on  the  day  of  the  hospital  admission
ere  excluded.  Shock  was  deﬁned  as  the  presence  of  nar-
ow  pulse  pressure,  arterial  hypotension  for  age  associated
ith  cyanosis,  lethargy,  or  coma.  This  study  also  excluded
ases  with  lack  of  information  from  the  patient’s  medical
hart  or  those  with  clinical  and/or  laboratory  evidence  of
ther  acute  febrile  diseases,  such  as  pneumonia,  acute  otitis
edia,  and  sinusitis.  Two  local  research  ethics  committees
pproved  this  study.
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Dengue  diagnosis  was  deﬁned  according  to  the  Brazil-
an  Ministry  of  Health  criteria.19 A  case  was  considered
onﬁrmed  when  it  met  the  following  criteria:  a  positive
ample  in  the  detection  of  viral  RNA  by  RT-PCR  (reverse
ranscription  polymerase  chain  reaction),  ELISA  (enzyme-
inked  immunosorbent  assay)  for  IgM  antibodies;  IgM  or
gG  seroconversion  in  paired  samples,  by  ELISA;  or  by  the
linical-epidemiological  criterion:  clinical  picture  consistent
ith  dengue,  epidemiological  link  to  conﬁrmed  dengue  case,
nd  absence  of  laboratory  conﬁrmation  of  other  diagnoses
onsistent  with  the  age  bracket.19 Data  collection  in  medical
harts  was  performed  by  medical  students  or  pediatricians
rained  for  this  purpose,  using  a  standardized  form  for  the
tudy.
The  outcome  variable  ‘‘Serious  dengue  disease’’  was
eﬁned  as  the  occurrence  of  death  or  the  use  of  amines,
notropes,  colloids,  mechanical  ventilation,  non-invasive
entilation,  peritoneal  dialysis  or  hemodialysis,  not  con-
idered  under  the  classiﬁcations  prevailing  at  the  time.19
he  explanatory  variables  included  socio-demographic  data,
linical  history,  physical  examination  on  the  ﬁrst  day  of
ospitalization,  and  initial  hematological  and  biochemical
aboratory  test  results.  Arterial  hypotension  was  deﬁned
ccording  to  age  bracket:  systolic  pressure  (SAP)  <100  mmHg
or  children  ≥12  years,  SAP  <  95  mmHg  for  ≥6  to  <12  years,
AP  <  90  mmHg  for  ≥2  to  <6  years,  SAP  <  85  mmHg  for  ≥1  to
2  years,  and  SAP  <  70  mmHg  for  ≥6  months  to  <1  year.8 In
namnesis,  asthma  reported  in  medical  charts  was  not  clin-
cally  classiﬁed;  bleeding  was  deﬁned  by  epistaxis,  gingival,
r  gastrointestinal  bleeding.  In  physical  examination,  severe
emorrhage  was  deﬁned  by  gastrointestinal  or  pulmonary
leeding;  pleural  effusion  was  conﬁrmed  by  chest  X-ray  or
ltrasound.  Serum  albumin  was  evaluated  as  a  continuous
nd  as  a  dichotomous  variable.  For  the  last,  this  study  used
he  cutoff  point  of  3.0  g/dL;  above  this  there  is  no  indica-
ion  for  albumin  administration.  Liver  injury  was  evaluated
hrough  aspartate  aminotransferase  (AST  >  40  UI/L)  and  ala-
ine  aminotransferase  (ALT  >  56  UI/L).
The  data  were  entered  into  EpiData  3.1  (Lauritsen  JM.
Ed.)  EpiData  Data  Entry,  Data  Management  and  basic  Sta-
istical  Analysis  System.  Dinamarca)  and  analyzed  in  Stata
3  (StataCorp.  2013.  Stata  Statistical  Software:  Release
3.  College  Station,  USA).  Frequencies  and  proportions
ere  calculated  for  the  categorical  variables  and  medians
ith  the  respective  interquartile  intervals  (IQI)  for  age  in
ears,  time  of  fever  until  onset  of  symptoms,  and  hema-
ological  and  biochemical  laboratory  parameters.  Fisher’s
xact  test  was  calculated  for  categorical  variables  and  the
ann--Whitney  test  was  utilized  for  continuous  variables
non-normal  distribution)  to  assess  the  association  between
hese  variables  and  serious  dengue  disease.  When  the  asso-
iation  was  statistically  signiﬁcant  (p  <  0.05),  the  following
ccuracy  measures  were  calculated  for  the  categorical
ariables  with  their  respective  95%  conﬁdence  intervals:
ensitivity  (Se),  speciﬁcity  (Sp),  positive  and  negative  pre-
ictive  values  (PPV  and  NPV),  and  positive  and  negative
ikelihood  ratios  (PLR,  NLR).  Adequate  values  were  deﬁned
s  PLR  >  5  and  NLR  ≤0.20.  For  the  continuous  variables, receiver  operating  characteristic  (ROC)  curve  was  con-
tructed  in  order  to  estimate  the  area  under  the  curve  (AUC)
ith  the  respective  95%  conﬁdence  interval.
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Table  1  Clinical  history  of  hospitalized  children  with  dengue.
Variables  Serious  dengue  diseasea p-Valueb
Yes  (n  =  23) No  (n  =  122)
n  %  n  %
Abdominal  pain  17  73.9  83  68.0  0.633
Anorexia 8  34.8  42  34.4  1.000
Arthralgia 3  13.0 4  3.3  0.080
Asthma 3  13.0 3  2.5  0.050
Bleedingc 15  65.2 42  34.4 0.009
Coughing 2  8.7  12  9.8  1.000
Diarrhea 7  30.4  27  22.1  0.424
Dizziness 2  8.7  7  5.7  0.635
Dyspnea 3  13.0  7  5.7  0.197
Exanthema  4  17.4  19  15.6  0.763
Headache 13  56.5  68  55.7  0.566
Hypotension  2  8.7  6  4.9  0.613
Itching 4  17.4  24  19.7  1.000
Lethargy 12  52.2  3  2.5  <0.001
Myalgia 7  30.4  39  32.0  1.000
Petechiae 7  30.4  29  23.8  0.599
Prostration 12  52.2  37  30.3  0.055
Retro-orbital  pain  3  13.0  12  9.8  0.708
Vomiting 17  73.9  95  77.9  0.786
a Serious dengue disease: death, use of amines, inotropes, colloids, non-invasive or mechanical ventilation, peritoneal dialysis or
hemodialysis.
b Fisher’s exact test.
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tHistory of epistaxis, gingival or gastrointestinal bleeding.
Results
Of  the  total  of  164  children  hospitalized  with  suspicion  of
dengue,  19  were  excluded:  one  dengue  diagnosis  was  ruled
out  by  laboratory  results,  three  already  presented  at  the
day  of  hospitalization  a  clinical  condition  consistent  with
DSS,  and  15  were  ruled  out  due  to  the  diagnosis  of  other
diseases  or  lack  of  information  on  the  patient  chart.  The
ﬁnal  sample  included  145  patients,  the  majority  female
(53.1%),  black  or  brown  (56.6%),  residing  in  the  city  of  Rio  de
Janeiro  (74.5%),  and  with  at  least  one  prior  medical  consul-
tation  (88.3%).  Most  of  the  children  were  2--11  years  (69%),
21.4%  12  or  more  years,  and  9.2%  less  than  2  years  of  age.
Only  three  patients  had  a  previous  history  of  dengue,  of
whom  none  were  classiﬁed  as  serious  dengue  disease.  Of  the
145  cases,  97  were  conﬁrmed  by  laboratory  and  48  by  the
clinical-epidemiological  criterion,  without  statistical  differ-
ence  across  serious  and  non-serious  dengue  (p  =  0.436).
Patients  who  evolved  to  serious  dengue  disease  rep-
resented  15.9%  of  the  sample.  Both  groups  were  mostly
represented  by  children  aged  2--11  years  (serious  =  78.3%  and
non-serious  =  67.2%),  without  statistical  difference  in  rela-
tion  to  those  less  than  2  years  and  12--18  years  (p  =  0.167
for  Fisher’s  exact  test).  Duration  of  fever  in  days  was
slightly  lower  in  this  subgroup  of  patients  (serious:  Md  =  3.0,
IQI  =  2.0--4.5;  non-serious:  Md  =  4.0,  IQI  =  3.0--5.0;  p  =  0.062).
History  of  asthma  (p  =  0.051),  report  of  lethargy  or  bleed-
ing,  and  the  identiﬁcation  of  lethargy,  dyspnea,  irritability,
p
s
rleeding,  abdominal  distension,  edema,  altered  breath
ounds,  or  pleural  effusion  on  physical  examination  at  hos-
ital  admission  were  more  frequent  in  patients  with  serious
utcomes  (Tables  1  and  2).
Cases  that  progressed  toward  serious  dengue  disease  pre-
ented  lower  values  of  hematocrit,  hemoglobin,  platelet
ount,  and  serum  albumin  than  other  forms,  while  leuko-
yte  count  was  higher  in  serious  dengue.  In  both  groups,
ST  levels  were  elevated  while  ALT  levels  were  below  the
ormal  range  (p  >  0.05;  Table  3).
Although  present  in  only  half  of  the  serious  dengue  cases,
ethargy,  reported  in  the  history  or  identiﬁed  in  the  ini-
ial  physical  examination,  was  the  single  clinical  sign  with
he  highest  positive  likelihood  ratios  (LR+  =  21.2  and  19.4,
espectively;  Table  4).  Presence  of  irritability  and  history
f  asthma  were  associated  with  a  moderate  increase  in  the
ikelihood  of  evolving  to  serious  dengue  disease  (LR+  =  5.3
nd  6.63,  respectively).  Pleural  effusion  and  abdominal  dis-
ension  were  the  signs  with  the  highest  sensitivity  (82.6%)
nd  negative  predictive  value  (95.3%  and  96.1%),  besides
howing  the  lowest  LR−  (0.26  and  0.22).  The  AUC  for  total
eukocyte  count  was  0.645  (0.526--0.765).  The  duration  of
ever  and  other  laboratory  values  presented  AUC  ≤0.5  (data
ot  shown).  Abdominal  distension  and  pleural  effusion  were
he  signs  with  the  highest  sensitivity  (82.6%)  and  negative
redictive  value  (96.1%  and  95.3%,  respectively),  besides
howing  the  lowest  negative  likelihood  ratios  (0.22  and  0.26,
espectively).
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Table  2  First  clinical  exam  of  hospitalized  children  with  dengue.
Physical  exam  Serious  dengue  diseasea p-Valueb
Yes  (n  =  23)  No  (n  =  122)
n  %  n  %
Abnormal  breath  sounds 18  78.3 42  34.4  <0.001
Abdominal distension 19  82.6 24  19.7  <0.001
Abdominal pain 18  78.3 81  66.4 0.333
Dehydration  5  21.7  33  27.0  0.797
Dyspnea 7  30.4  11  9.0  0.010
Edema 11  47.8  20  16.4  0.002
Exanthema  2  8.7  12  9.8  1.000
Hepatomegaly  9  39.1  28  23.0  0.120
Irritability 5  21.7  4  3.3  0.005
Lethargy 11  47.8  3  2.5  <0.001
Petechiae 8  34.8  41  33.6  1.000
Pleural effusionc 19  82.6  40  32.8  <0.001
Severe hemorrhaged 11  47.8  15  12.3  <0.001
a Serious dengue disease: death, use of amines, inotropes, colloids, non-invasive or mechanical ventilation, peritoneal dialysis or
hemodialysis.
b
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oFisher’s exact test.
c Conﬁrmed by chest X-ray or ultrasound.
d Gastrointestinal or pulmonary bleeding.
iscussion
his  study  showed  that  lethargy,  reported  in  the  history
r  identiﬁed  in  the  physical  examination,  was  the  clinical
ign  that  best  discriminates  patients  who  progress  toward
erious  dengue  disease.  Asthma  and  irritability  showed
oderate  positive  likelihood  ratios,  involving  increased
robability  of  serious  dengue  when  present.  Pleural  effu-
ion  and  abdominal  distension  showed  the  lowest  negative
ikelihood  ratios,  meaning  that  patients  without  these  signs
t  hospital  admission  were  less  likely  to  evolve  to  serious
engue  disease.  However,  the  clinical  evolution  corrobo-
ates  the  importance  of  early  diagnosis,  considering  the
apid  evolution  of  dengue,  in  which  the  most  critical  period
s  defervescence.20,21 Bleeding  was  more  frequent  in  serious
engue  cases  but  did  not  reach  good  accuracy.
T
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Table  3  Median  and  interquartile  interval  (IQI)  of  the  ﬁrst  labora
Variables  Seriou
Yes  (n  =  23)  
n  Median  (IQI)  
AST  (UI/L)  22  81.0  (67.0--118.0)  
ALT (UI/L)  21  32.0  (25.0--80.0)  
Hemoglobin  23  12.9  (11.1--14.3)  
Hematocrit  (%)  23  36.0  (31.8--41.0)  
Leucocytes  (×1000  mm−3)  23  6.79  (4.31--8.84)  
Platelets (×1000  mm−3)  23  34.0  (20.0--44.0)  
Serum albumin  (g/dL) 21  2.7  (2.3--3.0)  
AST, aspartate aminotransferase; ALT, alanine aminotransferase.
a Serious dengue disease: death, use of amines, inotropes, colloids
hemodialysis.
b Mann-Whitney test.These  results  are  similar  to  those  of  other  studies
emonstrating  that  lethargy,17,22 irritability,17 abdominal
istension,  and  pleural  effusion10,11 were  associated  to
everity.  However,  hematocrit  was  lower  in  patients  with
erious  disease.  This  ﬁnding  can  be  explained  by  the  fact
hat  88.3%  of  the  present  patients  were  referred  from  other
ealth  services  and  may  have  received  ﬂuid  replacement
rior  to  hospitalization.  A  study  conducted  in  the  Domini-
an  Republic  found  that  anemia  was  associated  with  serious
engue.23
The  serum  albumin  was  lower  in  the  group  with  the  worse
utcome,  which  was  also  found  in  another  Brazilian  study.24his  result  is  in  accordance  with  the  pathogenesis  of  dengue,
n  which  the  endothelial  lesion  with  resulting  plasma  leakage
s  the  most  important  marker  for  evolution  to  severe  forms,
specially  in  children.25 The  high  AST  serum  levels  in  the
tory  exam  of  hospitalized  children  with  dengue.
s  dengue  diseasea p-Valueb
No  (n  =  122)
n  Median  (IQI)
98  84.0  (58.0--118.0)  0.812
97  37.0  (23.0--64.0)  0.819
116  13.9  (12.5--15.2)  0.019
122  40.6  (36.7--44.4)  0.008
119  5.0  (3.3--6.97)  0.028
122  36.95  (27.0--76.8)  0.049
104  3.3  (3.0--3.7)  <0.001
, non-invasive or mechanical ventilation, peritoneal dialysis or
Serious
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Table  4  Accuracy  of  clinical  signs  and  symptoms  identiﬁed  in  the  anamnesis  or  the  ﬁrst  physical  examination  of  hospitalized  children  with  serious  dengue  disease.a
Variables Se  %  (95%  CI) Sp  %  (95%  CI) PPV  %  (95%  CI) NPV  %  (95%  CI) PLR  (95%  CI) NLR  (95%  CI)
History  of  asthma 13.0  (2.8--33.6) 97.5  (93.0--99.5) 50.0  (11.8--88.2) 85.6  (78.7--91.0) 5.30  (1.14--24.70) 0.89  (0.76--1.05)
History of  bleedingb 65.2  (42.7--83.6) 65.6  (56.4--73.9) 26.3  (15.5--39.7) 90.9  (82.9--96.0) 1.89  (1.29--2.79) 0.53  (0.30--0.94)
History of  lethargy 52.2  (30.6--73.2) 97.5  (93.0--99.5) 80.0  (51.9--95.7) 91.5  (85.4--95.7) 21.2  (6.49--69.30) 0.49  (0.32--0.75)
Abdominal distension 82.6  (61.2--95.0) 80.3  (72.2--87.0) 44.2  (29.1--60.1) 96.1  (90.3--98.9) 4.20  (2.80--6.29) 0.22  (0.09--0.53)
Abnormal breath  sounds 78.3  (56.3--92.5) 65.6  (56.4--73.9) 30.0  (18.8--43.2) 94.1  (86.8--98.1) 2.27  (1.64--3.15) 0.33  (0.15--0.73)
Dyspnea 30.4  (13.0--52.9) 91.0  (84.4--95.4) 38.9  (17.3--64.3) 87.4  (80.3--92.6)  3.38  (1.46--7.79)  0.76  (0.58--1.01)
Edema 47.8  (26.8--69.4) 83.6  (75.8--89.7) 35.5  (19.2--54.6) 89.5  (82.3--94.4)  2.92  (1.62--5.24)  0.62  (0.42--0.93)
Irritability 21.7  (7.5--43.7) 96.7  (91.8--99.1) 55.6  (21.2--86.3) 86.8  (79.9--92.0)  6.63  (1.92--22.8)  0.81  (0.65--1.01)
Lethargy 47.8  (26.8--69.4)  97.5  (93.0--99.5)  78.6  (49.2--95.3)  90.8  (84.5--95.2)  19.40  (5.88--64.30)  0.54  (0.36--0.79)
Pleural effusionc 82.6  (61.2--95.0)  67.2  (58.1--75.4)  32.2  (20.6--45.6)  95.3  (88.5--98.7)  2.52  (1.84--3.46)  0.26  (0.10--0.64)
Serum albumin  <3.0  g/dL  60.9  (38.5--80.3)  78.7  (70.4--85.6)  35.0  (20.6--51.7)  91.4  (84.4--96.0)  2.86  (1.78--4.58)  0.50  (0.30--0.84)
Severe hemorrhaged 47.8  (26.8--69.4)  87.7  (80.5--93.0)  42.3  (23.4--63.1)  89.9  (83.0--94.7)  3.89  (2.06--7.36)  0.60  (0.40--0.88)
Se, sensitivity; Sp, speciﬁcity; PPV, positive predictive value; NPV, negative predictive value; PLR, positive likelihood ratio; NLR, negative likelihood ratio; 95% CI, 95% conﬁdence interval.
a Serious dengue disease: death, use of amines, inotropes, colloids, non-invasive or mechanical ventilation, peritoneal dialysis or hemodialysis.
b History of epistaxis, gingival or gastrointestinal bleeding.
c Conﬁrmed by chest X-ray or ultrasound.
d Gastrointestinal or pulmonary bleeding.
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170  
resent  pediatric  sample  was  in  accordance  with  two  other
tudies.24,26
In  the  present  study,  although  bleeding  was  more
requent  in  serious  cases,  both  groups  presented  throm-
ocytopenia.  The  absence  of  association  between  throm-
ocytopenia  and  bleeding  was  also  found  in  a  sample  of
ospitalized  children  from  Sri  Lanka.26 Leukocyte  count  was
igher  in  serious  dengue,  whose  association  was  not  consis-
ent  in  two  other  studies.26,27
The  current  study  has  strengths  and  limitations.  This
tudy’s  strength  is  the  evaluation  of  a  wide  set  of  clini-
al  signs  and  symptoms  as  well  as  laboratory  exams  using
urrently  recommended  accuracy  measures.28 In  addition,
he  criterion  adopted  in  this  study  for  serious  dengue  dis-
ase  was  deﬁned  by  death  or  medical  interventions,  thus
inimizing  the  diagnostic  incorporation  bias.  The  major-
ty  of  the  studies11,17,29 were  limited  to  assessing  the  odds
atio  and  adopting  composite  criteria  consisting  of  one  or
ore  predictive  variables.  The  present  study’s  sample  size
as  similar  to  other  hospital-based  studies  in  children.24,26,27
owever,  there  were  also  some  limitations,  such  as  over-
stimation  of  the  diagnostic  accuracy  of  pleural  effusion,
he  presence  of  which  can  be  determinant  for  the  use  of
echanical  ventilation.  The  study  was  also  retrospective,28
nd  generalization  of  the  results  is  limited  to  hospitalized
hildren  at  school  age.
In  conclusion,  this  study  showed  that  lethargy,  abdom-
nal  distension,  and  pleural  effusion  were  the  signs  with
he  greatest  diagnostic  accuracy;  and  that  bleeding,  severe
emorrhage,  hemoconcentration,  and  thrombocytopenia
ere  not  associated  to  severity  in  this  setting.  Thus,  in
ediatric  referral  hospitals,  the  absence  of  hemoconcentra-
ion  does  not  imply  absence  of  plasma  leakage,  particularly
n  patients  who  have  received  previous  ﬂuid  replacement.
n  this  setting,  hypoalbuminemia  and  pleural  effusion  rep-
esented  better  markers  of  serious  dengue.  Moreover,  the
esults  related  to  lethargy  and  pleural  effusion  were  consis-
ent  with  the  warning  signs  listed  in  the  revised  2009  WHO
engue  classiﬁcation.30
These  ﬁndings  can  contribute  to  knowledge  on  dengue
linical  epidemiology  in  children  admitted  at  pediatric  refer-
al  hospitals.  Future  prospective  studies  should  include
hildren  in  initial  stages  of  the  disease  to  identify  earlier
igns  of  severity,  more  adequate  for  case  management  in
rimary  care.
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